Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion to everolimus-based CNI-free therapy in stable kidney transplant recipients
2010-018791-24Phase 4Active
- Sponsor
- Kliniken der Stadt Köln
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus, sponsored by Kliniken der Stadt Köln. Primary endpoint: Evolution of renal function between baseline and Month 12 by GFR slope. Started Jan 2011; status: active.
02
Drugs
everolimus
Beyond the preview
Go deeper on 2010-018791-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018791-24.